Korea Investment Corp’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$483M Sell
1,977,874
-19,954
-1% -$4.65M 1% 15
2025
Q4
$413M Buy
1,997,828
+411,886
+26% +$81.5M 0.81% 16
2025
Q3
$294M Sell
1,585,942
-247,334
-13% -$42.4M 0.6% 25
2025
Q2
$280M Sell
1,833,276
-17,311
-0.9% -$2.66M 0.62% 23
2025
Q1
$307M Buy
1,850,587
+32,206
+2% +$5.04M 0.74% 22
2024
Q4
$263M Sell
1,818,381
-64,911
-3% -$10.1M 0.62% 24
2024
Q3
$305M Buy
1,883,292
+119,333
+7% +$19M 0.72% 22
2024
Q2
$258M Sell
1,763,959
-47,352
-3% -$7.04M 0.65% 23
2024
Q1
$287M Sell
1,811,311
-60,514
-3% -$9.63M 0.73% 21
2023
Q4
$293M Sell
1,871,825
-31,689
-2% -$4.86M 0.77% 20
2023
Q3
$296M Sell
1,903,514
-123,356
-6% -$20.4M 0.87% 18
2023
Q2
$335M Sell
2,026,870
-148,166
-7% -$23.9M 0.94% 18
2023
Q1
$337M Buy
2,175,036
+56,042
+3% +$9.05M 0.98% 13
2022
Q4
$374M Sell
2,118,994
-362,190
-15% -$62.5M 1.18% 9
2022
Q3
$405M Buy
2,481,184
+186,598
+8% +$31.6M 1.25% 8
2022
Q2
$407M Buy
2,294,586
+154,770
+7% +$27.6M 1.25% 8
2022
Q1
$379M Buy
2,139,816
+235,515
+12% +$40.1M 0.94% 13
2021
Q4
$326M Buy
1,904,301
+356,525
+23% +$58.4M 0.85% 16
2021
Q3
$250M Sell
1,547,776
-85,612
-5% -$14.6M 0.75% 21
2021
Q2
$269M Buy
1,633,388
+63,103
+4% +$10.4M 0.77% 17
2021
Q1
$258M Buy
1,570,285
+173,640
+12% +$28.1M 0.81% 19
2020
Q4
$220M Sell
1,396,645
-436,852
-24% -$64.5M 0.66% 30
2020
Q3
$273M Sell
1,833,497
-140,549
-7% -$20.8M 0.96% 15
2020
Q2
$278M Sell
1,974,046
-115,600
-6% -$16.8M 1.02% 15
2020
Q1
$274M Sell
2,089,646
-25,800
-1% -$3.66M 1.2% 13
2019
Q4
$309M Buy
2,115,446
+108,800
+5% +$14.8M 1.13% 15
2019
Q3
$260M Buy
2,006,646
+13,949
+0.7% +$1.84M 1.1% 14
2019
Q2
$278M Buy
1,992,697
+1,000
+0.1% +$138K 1.19% 9
2019
Q1
$278M Buy
1,991,697
+133,229
+7% +$17.8M 1.25% 10
2018
Q4
$240M Buy
1,858,468
+100
+0% +$13.9K 1.3% 9
2018
Q3
$257M Sell
1,858,368
-150,993
-8% -$20.1M 1.18% 10
2018
Q2
$244M Sell
2,009,361
-136,500
-6% -$17M 1.11% 12
2018
Q1
$275M Sell
2,145,861
-38,740
-2% -$5.24M 1.28% 8
2017
Q4
$305M Buy
2,184,601
+84,200
+4% +$11.7M 1.39% 8
2017
Q3
$273M Sell
2,100,401
-80,500
-4% -$10.7M 1.26% 9
2017
Q2
$289M Buy
2,180,901
+50,868
+2% +$6.49M 1.34% 9
2017
Q1
$265M Buy
2,130,033
+596,134
+39% +$71.2M 1.32% 9
2016
Q4
$177M Buy
1,533,899
+47,329
+3% +$5.47M 0.85% 21
2016
Q3
$176M Buy
1,486,570
+182,730
+14% +$22.2M 0.94% 16
2016
Q2
$158M Buy
1,303,840
+350,600
+37% +$39.8M 0.94% 16
2016
Q1
$103M Buy
953,240
+16,103
+2% +$1.67M 0.75% 23
2015
Q4
$96.3M Buy
937,137
+41,300
+5% +$4.15M 0.67% 24
2015
Q3
$83.6M Buy
895,837
+41,137
+5% +$3.98M 0.67% 22
2015
Q2
$83.3M Sell
854,700
-48,900
-5% -$4.9M 0.71% 19
2015
Q1
$90.9M Sell
903,600
-216,800
-19% -$22M 0.71% 22
2014
Q4
$117M Sell
1,120,400
-152,700
-12% -$16.1M 0.96% 12
2014
Q3
$136M Sell
1,273,100
-235,200
-16% -$24.4M 1.11% 10
2014
Q2
$158M Buy
1,508,300
+36,100
+2% +$3.65M 1.31% 8
2014
Q1
$145M Buy
1,472,200
+310,200
+27% +$28.8M 1.28% 7
2013
Q4
$106M Buy
1,162,000
+4,100
+0.4% +$378K 1.01% 9
2013
Q3
$100M Buy
1,157,900
+109,500
+10% +$9.82M 1.07% 10
2013
Q2
$90M Buy
+1,048,400
New +$89M 1.08% 11

Other funds holding JNJ

Korea Investment Corp's JNJ Position: Q1 2026 in Review

Korea Investment Corp reduced its Johnson & Johnson (JNJ) stake by 1% in Q1 2026, selling an estimated $4.65M and leaving 1,977,874 shares worth $483M. The position accounts for 1% of the portfolio, ranked #15.

Korea Investment Corp first reported a position in JNJ in Q2 2013 and has held it in 52 quarters since. 4,631 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Korea Investment Corp held 1,977,874 shares of Johnson & Johnson worth $483M as of Q1 2026.
  • Korea Investment Corp sold 19,954 Johnson & Johnson shares in Q1 2026, an estimated $4.65M.
  • Johnson & Johnson made up 1% of Korea Investment Corp's portfolio in Q1 2026, its #15 holding.
  • Korea Investment Corp first reported a position in Johnson & Johnson in Q2 2013 and has held it in 52 quarters since.
  • 4,631 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Korea Investment Corp's 13F filing for Q1 2026, filed 13 May 2026.